Change in bone marrow morphology with treatment
. | Pretreatment . | . | . | After cycle 1 . | . | . | After cycle 2 . | . | . | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ID no. . | Cellularity . | M/E ratio . | MK/LPF . | Cellularity . | M/E ratio . | MK/LPF . | Cellularity . | M/E ratio . | MK/LPF . | ||||||
| UPN 1 | Hyper | 0.8 | 4 | Hyper | 0.7 | 10 | Hyper | 0.6 | 13 | ||||||
| UPN 3 | Hyper | 0.8 | 2-3 | — | — | — | Hyper | 0.3 | 6 | ||||||
| UPN 5 | Norm | 2 | 2 | Norm | 0.8 | 6 | Norm | 0.5 | 6 | ||||||
| UPN 7 | Hyper | 1 | 1 | Hyper | 0.3 | 8 | Hyper | 0.03 | 13 | ||||||
. | Pretreatment . | . | . | After cycle 1 . | . | . | After cycle 2 . | . | . | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ID no. . | Cellularity . | M/E ratio . | MK/LPF . | Cellularity . | M/E ratio . | MK/LPF . | Cellularity . | M/E ratio . | MK/LPF . | ||||||
| UPN 1 | Hyper | 0.8 | 4 | Hyper | 0.7 | 10 | Hyper | 0.6 | 13 | ||||||
| UPN 3 | Hyper | 0.8 | 2-3 | — | — | — | Hyper | 0.3 | 6 | ||||||
| UPN 5 | Norm | 2 | 2 | Norm | 0.8 | 6 | Norm | 0.5 | 6 | ||||||
| UPN 7 | Hyper | 1 | 1 | Hyper | 0.3 | 8 | Hyper | 0.03 | 13 | ||||||
Cellularity indicates bone marrow aspirate cellularity; M/E ratio, myeloid to erythroid ratio; MK/LPF, number of megakaryocytes per low-power microscope field; and —, not done.